Synthesis of some azacyclic derivatives as potential antineoplastic agents / Manal Abdelfattah Ezzat Salem ; Supervised Nehad Abouelmagd Elsayed , Reem Khidr Arafa , Riham Francois George
Material type: TextLanguage: English Publication details: Cairo : Manal Abdelfattah Ezzat Salem , 2015Description: 134 P. : charts , facsimiles ; 25cmOther title:- تشييد بعض المشتقات الحلقية النيتروجينية كمضادات للأورام السرطانية [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.05.M.Sc.2015.Ma.S (Browse shelf(Opens below)) | Not for loan | 01010110067152000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.08.05.M.Sc.2015.Ma.S (Browse shelf(Opens below)) | 67152.CD | Not for loan | 01020110067152000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Pharmacy - Department of Pharmaceutical Chemistry
Cancer represents a group of diseases affecting body tissues causing uncontrolled cell proliferation, tissue invasion and apoptosis. Investigations into cancer therapy have led to the discovery of the active antiangiogenic VEGFR inhibitor vatalanib. This promoted us to design novel phthalazinone derivatives, bearing the same backbone scaffold and having the same pharmacophoric features as vatalanib. Molecular modeling techniques were used to support the design of these compounds as potential antiangiogenic agents by inhibition of vascular endothelial growth factor receptor (VEGFR). The synthesized compounds can be visualized according to the side chain substitution patterns on the phthalazinone core as Mannich base derivatives (IVa-j), substituted benzylidene derivatives (VIIa-g), substituted phenylethylidene derivatives (VIIIa-d), carboxamide derivatives (IXa-d), benzo/3-pyridinylhydrazide derivatives (Xa-c) and substituted pyrazole derivatives (XIa-c). This study covers the synthesis of thirty one novel compounds that were evaluated for their antitumor activity at National Cancer Institute, Cairo University, Egypt, against (MCF-7) breast cancer cell line and (HCT-116) colon cancer cell line. Moreover, the four most active compounds were evaluated for their ability to inhibit (VEGFR) against colon cancer cell line at Vacsera, Egypt
Issued also as CD
There are no comments on this title.